Agilent Technologies, Inc. $A Stock: Robeco Schweiz AG Trims Stake

Robeco Schweiz AG lowered its stake in Agilent Technologies, Inc. (NYSE:A) by 7.5% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 931,998 shares of the medical research company’s stock after selling 75,587 shares during the quarter. Agilent Technologies comprises approximately 2.9% of Robeco Schweiz AG’s holdings, making the stock its 8th largest holding. Robeco Schweiz AG’s holdings in Agilent Technologies were worth $160,593,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in A. Markowski Investments purchased a new position in shares of Agilent Technologies during the second quarter valued at about $27,000. Cedar Mountain Advisors LLC bought a new stake in shares of Agilent Technologies in the first quarter worth about $27,000. Keating Financial Advisory Services Inc. bought a new stake in shares of Agilent Technologies in the second quarter worth about $31,000. Osterweis Capital Management Inc. purchased a new stake in shares of Agilent Technologies in the second quarter worth about $43,000. Finally, Investors Research Corp purchased a new stake in shares of Agilent Technologies in the second quarter worth about $51,000.

Insider Transactions at Agilent Technologies

In other news, Director Mikael Dolsten sold 634 shares of the firm’s stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the sale, the director directly owned 4,924 shares of the company’s stock, valued at $745,395.12. This trade represents a 11.41% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Stifel Nicolaus increased their price target on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research note on Thursday, August 27th. The Goldman Sachs Group lifted their price objective on Agilent Technologies from $175.00 to $185.00 and gave the stock a “buy” rating in a research note on Monday, September 21st. Royal Bank Of Canada upped their price objective on Agilent Technologies from $155.00 to $185.00 and gave the stock an “outperform” rating in a report on Thursday, August 27th. TD Cowen upped their price objective on Agilent Technologies from $180.00 to $196.00 and gave the stock a “buy” rating in a report on Tuesday, October 13th. Finally, Piper Sandler increased their target price on Agilent Technologies from $150.00 to $160.00 and gave the company a “neutral” rating in a research report on Friday, August 28th. Seventeen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $181.00.

Agilent Technologies Stock Performance

Agilent Technologies stock opened at $172.98 on Friday. The company’s 50-day moving average price is $161.48 and its 200-day moving average price is $139.62. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $179.10. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. The company has a market cap of $48.77 billion, a PE ratio of 34.05, a price-to-earnings-growth ratio of 2.63 and a beta of 1.21.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. During the same period in the prior year, the company earned $1.37 EPS. The business’s revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, equities research analysts forecast that Agilent Technologies, Inc. will post 6.20 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th will be given a dividend of $0.2550 per share. The ex-dividend date is Tuesday, October 6th. This represents a $1.02 dividend on an annualized basis and a yield of 0.6%. Agilent Technologies’s dividend payout ratio is 20.08%.

Agilent Technologies Profile

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.